NCT03923920View on ClinicalTrials.gov

Screening for Systemic Amyloidosis Via the Ligamentum Flavum

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

October 4, 2021

Study Completion Date

December 2, 2021

Conditions
AmyloidAmyloidosisSpinal StenosisTransthyretin AmyloidosisPrimary Amyloidosis of Light Chain Type
Interventions
PROCEDURE

Biopsy

During clinically-scheduled spinal stenosis surgery, ligamentum flavum tissue (which may contain surrounding tissue and subcutaneous fat) that is removed during the procedure will be sent to pathology to be analyzed with amyloid-specific staining.

Trial Locations (1)

44195

Cleveland Clinic, Cleveland

All Listed Sponsors
lead

The Cleveland Clinic

OTHER

NCT03923920 - Screening for Systemic Amyloidosis Via the Ligamentum Flavum | Biotech Hunter | Biotech Hunter